Trial intelligence / Profile preview

UC-MSCs and Mononuclear Cells Infusion in T1DM

NCT01374854Phase 2Unknown

Sponsor
900th Hospital of Joint Logistics Support Force of PLA
Start
Jan 2009
Primary completion
Dec 2010
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of human umbilical cord mesenchymal stem cells in type 1 diabetes mellitus (T1D), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Status: unknown.

02

Drugs

human umbilical cord mesenchymal stem cells
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT01374854.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01374854.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call